Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural...

Psychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse...

PT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying...

Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine...

MYND Life Sciences Announces $3.5 Million Share Offering

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial...

Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural...

Psychedelic Research Bulletin: March 2022

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

Load more